Filing Details

Accession Number:
0001209191-16-106704
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-07 17:40:09
Reporting Period:
2016-03-03
Filing Date:
2016-03-07
Accepted Time:
2016-03-07 17:40:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000228 Henry Schein Inc HSIC Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 113136595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194347 P James Breslawski C/O Henry Schein, Inc.
135 Duryea Road
Melville NY 11747
Pres., Hsi & Ceo Global Dental Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Disposition 2016-03-03 7,166 $167.51 96,073 No 4 S Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2016-03-04 9,525 $0.00 105,598 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Footnotes
  1. The price reflects a weighted average of sales made at prices ranging from $167.27 to $167.69 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.
  2. Grant of restricted stock units (RSUs) pursuant to the Issuer's 2013 Stock Incentive Plan. Subject to certain exceptions, 65% will vest subject to (x) Issuer's achievement of a specified perf. goal and (y) reporting person's continued performance of services for the Issuer. 35% will vest subject to (x) passage of a specified period of time and (y) reporting person's continued performance of services for the Issuer. With respect to the perf.-based RSUs, if the continued service requirement is satisfied and achievement of the perf. goal (x) exceeds 100% of target, the Issuer may issue additional vested shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved in excess of 100% of target or (y) is less than 100% of target, the reporting person will surrender to the Issuer shares of common stock in an amount that corresponds to the incremental percentage of the perf. goal achieved that is below 100% of target (i.e., shortfall).